# US 2004/0072764 A1 · Composition, in particular cosmetic, containing 7-hydroxy dhea and/or 7-keto dhea and at least an isoflavonoid

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0072764 A1
- Document ID: US20040072764A1
- Status: Published application
- Kind: A1
- Application number: 10/433,489
- Filed: 2003-11-05
- Published: 2004-04-15
- Earliest claimed: 2000-12-15
- Assignees: L'oreal
- Inventors: Lionel Breton
- Web page: https://patentgrep.com/patent/US20040072764A1

## CPC

- A61K 8/498: {having 6-membered rings or their condensed derivatives, e.g. coumarin}
- A61K 8/63: Steroids; Derivatives thereof
- A61K 8/9789: Magnoliopsida [dicotyledons]
- A61P 17/00: Drugs for dermatological disorders
- A61P 17/16: Emollients or protectives, e.g. against radiation
- A61Q 19/08: Anti-ageing preparations
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

The invention concerns a composition containing, in a physiologically acceptable medium: (a) at least a DHEA derivative selected among 7-hydroxy DHEA and 7-keto DHEA, and (b) at least an isoflavonoid. The invention also concerns cosmetic and dermatological uses of said composition, in particular for preventing or treating actinic skin ageing symptoms.

## Claims

### Claim 1

A composition containing, in a physiologically acceptable medium: (a) at least one DHEA derivative chosen from 7-hydroxy-DHEA and 7-keto-DHEA, and (b) at least one isoflavonoid.

### Claim 2 (depends on 1)

The composition as claimed in claim 1, characterized in that the 7-hydroxy-DHEA is 7α-OH-DHEA.

### Claim 3 (depends on 1)

The composition as claimed in claim 1, characterized in that the 7-hydroxy-DHEA is 7β-OH-DHEA.

### Claim 4 (depends on 1, 2, 3)

The composition as claimed in any one of claims 1 to 3, characterized in that said isoflavonoid is chosen from isoflavonoids of natural origin.

### Claim 5 (depends on 4)

The composition as claimed in claim 4, characterized in that said isoflavonoid is chosen from isoflavones.

### Claim 6 (depends on 4, 5)

The composition as claimed in claim 4 or 5, characterized in that said isoflavonoid is chosen from daidzin, genistin, daidzein, formononetin, cuneatin, genistein, isoprunetin and prunetin, cajanin, orobol, pratensein, santal, junipegenin A, glycitein, afrormosin, retusin, tectorigenin, irisolidone, jamaicin, and their analogs and metabolites.

### Claim 7 (depends on 6)

The composition as claimed in claim 6, characterized in that said isoflavonoid is chosen from daidzein, genistein, glycitein, daidzin, genistin and glycitin.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6, 7)

The composition as claimed in any one of claims 1 to 7, characterized in that it is suitable for topical application to the skin.

### Claim 9 (depends on 8)

The composition as claimed in claim 8, characterized in that it contains from 0.0000001 to 10% by weight of DHEA derivative, relative to the total weight of the composition.

### Claim 10 (depends on 9)

The composition as claimed in claim 9, characterized in that it contains from 0.00001 to 5% by weight of DHEA derivative, relative to the total weight of the composition.

### Claim 11 (depends on 8, 9, 10)

The composition as claimed in any one of claims 8 to 10, characterized in that it comprises from 10−10% to 10% by weight of isoflavonoid, relative to the total weight of the composition.

### Claim 12 (depends on 11)

Composition as claimed in claim 11, characterized in that it comprises from 10−8% to 5% by weight of isoflavonoid, relative to the total weight of the composition.

### Claim 13 (depends on 1, 2, 3, 4, 5, 6, 7)

The composition as claimed in any one of claims 1 to 7, characterized in that it is suitable for administration by the oral route.

### Claim 14 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)

The cosmetic use of the composition as claimed in any one of claims 1 to 13 for the prevention or treatment of the signs of skin aging, in particular of actinic aging.

### Claim 15 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)

The cosmetic use of the composition as claimed in any one of claims 1 to 13 for preventing or controlling the formation of wrinkles and/or for improving skin tone and/or for increasing skin firmness.

### Claim 16 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)

The cosmetic use of the composition as claimed in any one of claims 1 to 13 for preventing or controlling the harmful effects of UV radiation on the skin.

### Claim 17 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)

The use of the composition as claimed in any one of claims 1 to 13 for the manufacture of a composition intended for preventing or controlling the harmful effects of UV radiation on the skin.
